Search results

Page results

• John McGrath

  John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.

• UCLH implements reusable theatre hats to improve sustainability

  UCLH is making the change from single use to named reusable fabric theatre hats for staff working in operating theatres.

• Discontinuation of MiniMed™ Mio™ Infusion sets

  Medtronic are discontinuing the MiniMed™ Mio™ Infusion sets. If you are currently using MiniMed™ Mio™ infusion sets, you will need to change to an alternative infusion set before 31 March 2023. After this date, MiniMed™ Mio™ infusion sets will no longer be available.

• Hundreds attend Research Open Day

  Learn more about how UCLH celebrated Research Open Day this month.

• Towards sustainable estates, facilities, technology and transport

  As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.

• Having proton beam therapy: information for teenagers aged 13-17

  Having proton beam therapy: information for teenagers aged 13-17 patient information.

• Towards engagement and education around sustainability

  Ensuring that UCLH staff understand the urgency of the climate crisis and support our net zero programme is crucial if we want to be successful in reaching our goal of net zero carbon emissions by 2031. Our patients must be kept informed of changes and we must work closely with other NHS organisations, including NHS England, if we are to deliver a successful programme. This page documents our progress to date.

• Getting to Grips with Anxiety - Two-part online workshop

  This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.

• Next-generation treatment for multiple myeloma shows early promise

  Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.

• Mixed sex accommodation and privacy

  Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay